2020-06-24
Positive results from Phase 2 study
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2020-06-24
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2022-12-12
Through a private placement the family-owned investment company Sandberg Development will become a new owner of COT…
Read more2022-12-05
Fredrik Sjöholm is since 2016 is VP Sales at Precise Biometrics and has a long relevant background within internatio…
Read more2022-11-25
In 2018 Sandberg Development invested in the water technology company SWATAB. Sandberg Development now acquires the…
Read more2022-11-10
Camurus' Interim Report for the third quarter, which was published today, showed that this was Camurus' financially…
Read more2022-11-01
Sandberg Development aim to improve sustainable and commercial solutions and to create new ones for the future. To a…
Read more